The Intestinal Fatty Acid Binding Protein Diagnosing Gut Dysfunction in Acute Pancreatitis A Pilot Study

被引:27
作者
Pan, Liya [1 ]
Wang, Xinying [1 ]
Li, Weiqin [1 ]
Li, Ning [1 ]
Li, Jieshou [1 ]
机构
[1] Nanjing Univ, Res Inst Gen Surg, Jinling Hosp, Sch Med, Nanjing 210002, Jiangsu, Peoples R China
关键词
intestinal fatty acid binding protein; gut dysfunction score; citrulline; GASTROINTESTINAL FAILURE SCORE; CRITICALLY-ILL PATIENTS; HYPOPERFUSION CONTRIBUTES; PARENTERAL-NUTRITION; ALLOGRAFT-REJECTION; ENTEROCYTE MASS; BARRIER FAILURE; BOWEL-SYNDROME; ORGAN FAILURE; PERMEABILITY;
D O I
10.1097/MPA.0b013e3181c79654
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objectives: To study the use of intestinal fatty acid binding protein (I-FABP) in diagnosing gut dysfunction in patients with acute pancreatitis (AP). Methods: Thirty-two patients with AP onset within 7 days were enrolled in our study. The severity of disease and the gut dysfunction were evaluated as follows: on admission, on the seventh day of disease attack, and on the third day after enteral nutrition. Serum levels of I-FABP, citrulline, and C-reactive protein (CRP) and the lactulose and mannitol absorption ratio in urine were measured in parallel. Results: The serum level of I-FABP increased on admission, and it was more pronounced in severe attacks. All patients had increased gut dysfunction score, serum level of CRP, and urine level of lactulose and mannitol absorption ratio with decreased serum level of citrulline. A positive correlation was found between the following pairs of measurement on admission: serum level of I-FABP and gut dysfunction score, serum level of I-FABP and Acute Physiology and Chronic Health Evaluation II score, I-FABP and serum level of CRP, and serum level of I-FABP and the length of ICU stay. A reverse correlation between the serum level of I-FABP and the serum level of citrulline was found. Conclusions: The serum level of I-FABP can be used for assessing the gut dysfunction and disease severity of AP.
引用
收藏
页码:633 / 638
页数:6
相关论文
共 41 条
[1]   Role of the gut in the course of severe acute pancreatitis [J].
Ammori, BJ .
PANCREAS, 2003, 26 (02) :122-129
[2]   Early increase in intestinal permeability in patients with severe acute pancreatitis: Correlation with endotoxemia, organ failure, and mortality [J].
Ammori, BJ ;
Leeder, PC ;
King, RFGJ ;
Barclay, GR ;
Martin, IG ;
Larvin, M ;
McMahon, MJ .
JOURNAL OF GASTROINTESTINAL SURGERY, 1999, 3 (03) :252-261
[3]   Bacterial translocation: Overview of mechanisms and clinical impact [J].
Balzan, Silvio ;
Quadros, Claudio de Almeida ;
de Cleva, Roberto ;
Zilberstein, Bruno ;
Cecconello, Ivan .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2007, 22 (04) :464-471
[4]   Gastrointestinal failure score in critically ill patients [J].
Berger, Mette M. ;
Oddo, Mauro ;
Lavanchy, Jerome ;
Longchamp, Corinne ;
Delodder, Frederik ;
Schaller, Marie-Denise .
CRITICAL CARE, 2008, 12 (06)
[5]   INTESTINAL PERMEABILITY - AN OVERVIEW [J].
BJARNASON, I ;
MACPHERSON, A ;
HOLLANDER, D .
GASTROENTEROLOGY, 1995, 108 (05) :1566-1581
[6]  
BRADLEY EL, 1993, ARCH SURG-CHICAGO, V128, P586
[7]   Intestinal permeability and irritable bowel syndrome [J].
Camilleri, M. ;
Gorman, H. .
NEUROGASTROENTEROLOGY AND MOTILITY, 2007, 19 (07) :545-552
[8]   Postabsorptive plasma citrulline concentration is a marker of absorptive enterocyte mass and intestinal failure in humans [J].
Crenn, P ;
Coudray-Lucas, C ;
Thuillier, F ;
Cynober, L ;
Messing, B .
GASTROENTEROLOGY, 2000, 119 (06) :1496-1505
[9]   Citrulline as a biomarker of intestinal failure due to enterocyte mass reduction [J].
Crenn, Pascal ;
Messing, Bernard ;
Cynober, Luc .
CLINICAL NUTRITION, 2008, 27 (03) :328-339
[10]  
Cronk Daniel R, 2006, Curr Surg, V63, P322, DOI 10.1016/j.cursur.2006.05.006